Cornell Belcher, Brilliant Corners Research's founder and president, and Brian Gardner, Stifel's chief Washington policy ...

Stifel has upgraded Alkermes (NASDAQ:ALKS) to buy from hold, citing increased confidence in the company’s narcolepsy drug ...

Investment bank B. Riley Financial said on Friday it had agreed to sell a portion its traditional wealth management business ...

B. Riley Financial Inc. agreed to sell a portion of its wealth-management business to Stifel Financial Corp. for as much as ...

B. Riley Financial is selling part of its Wealth Management business to Stifel Financial for $27M to $35M, focusing on core ...

In a report released yesterday, Steven Wieczynski from Stifel Nicolaus maintained a Buy rating on Wynn Resorts (WYNN – Research Report), ...

In his first quarterly earnings call with Wall Street analysts as Starbucks CEO on Wednesday night, Brian Niccol offered ...

Stifel lowered the firm’s price target on Crispr Therapeutics (CRSP) to $53 from $59 and keeps a Hold rating on the shares following the ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will present at the Stifel 2024 Healthcare Conference on Tuesday, ...

Eric Lyon, a former senior managing director, B. Riley Wealth Management, jumped to Kestra Investment Services at the start ...

Stifel Financial Corp. (NYSE:SF – Get Free Report) has received a consensus rating of “Hold” from the seven ratings firms that are covering the company, MarketBeat Ratings reports.